Tag Archives: OPOF

Best Low Price Stocks To Watch For 2018

A few weeks ago, I wrote about Hetty Green and how her advice to “act with thrift and shrewdness and be persistent” has paid off for us. I’ve been applying the exact same method to trading for years now, through several market pullbacks, and that persistence has resulted in a mountain of income and a nice track record of winners.

—Sponsored Link— 10 Tech Stocks That Will TRIPLE
Don’t throw your money away on risky tech startups and IPOs that don’t deliver. Instead, bank on these 10 high-growth tech stocks that offer a high likelihood of outperformance in the near-term and a chance of TRIPLING your money by the end of the year! You’ll find their names and buy-below prices when you click here now.

But there’s another important piece to maintaining a persistent approach…

You have to make sure that approach still works!

Now, that doesn’t mean you should second-guess yourself or constantly tinker with your strategy; just check in from time to time to make sure you’re still seeing the results you want.

Best Low Price Stocks To Watch For 2018: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Best Low Price Stocks To Watch For 2018: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

  • [By Paul Ausick]

    Tesaro Inc. (NASDAQ: TSRO) traded down about 10% Tuesday and posted a new 52-week low of $74.57 after Friday at $82.87. The 52-week high is $192.94. Volume was about 2 million, more than double the daily average of around 870,000 million shares. The maker of cancer therapeutics had no specific news.

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Tesaro (TSRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Best Low Price Stocks To Watch For 2018: Intercontinental Hotels Group(IHG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Liberum Capital reissued their hold rating on shares of InterContinental Hotels Group (LON:IHG) in a research report report published on Friday morning.

Hot Medical Stocks To Buy Right Now

Few industries have packed the potent gains that pot has shown over the past year.

The majority of pot stocks have seen double- and triple-digit increases from their early-year valuations.

The phrase marijuana millionaire is becoming more and more common as people just like you turn small stakes into fortunes.

2017 has been great for pot investors, but 2018 is only going to get better.

Growing public sentiment in favor of continued marijuana legalization, heavy investment from the financial worlds biggest names and new legislation allowing for new markets here and abroad…

It’s a perfect storm for big money in 2018.

A Quick Look Back

2017 was a banner year for the pot industry.

Nevada went fully legal, and to date 29 states now have legalized pot in some form or another.

Medical marijuana and now recreational pot have been huge drivers for this years market success.

Looking at the North American Marijuana Index year-to-date performance, pot plays are up a whopping 57.25%.

Hot Medical Stocks To Buy Right Now: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tandem Diabetes Care Inc (NASDAQ: TNDM) were down 58 percent to $2.25 after the company posted downbeat quarterly results.

    Cempra Inc (NASDAQ: CEMP) was down, falling around 59 percent to $7.69 after the FDA raised liver safety issues in its review of the company's experimental drug to treat community acquired pneumonia. Baird downgraded Cempra from Outperform to Underperform.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Lisa Levin]

    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.

Hot Medical Stocks To Buy Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

Hot Medical Stocks To Buy Right Now: SandRidge Mississippian Trust II(SDR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sandridge Mississippian Trust II (NYSE: SDR) dropped about 18% Monday to post a new 52-week low of $0.75 after closing at $0.95 on Friday. The 52-week high is $1.79. Volume was around 1.3 million, more than nine times the daily average of around 160,000. The company had no specific news.

Hot Medical Stocks To Buy Right Now: Iteris, Inc.(ITI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Hot Medical Stocks To Buy Right Now: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Top 10 High Tech Stocks To Watch Right Now

Photo Credit: JANEK SKARZYNSKI/AFP/Getty Images.

Everyone has heard of ICOs, but an older approach involving airdrops and hard forks is gaining new traction and holders of Bitcoin and Ethereum stand to benefit significantly if the trend continues.

In an ICO, participants contribute capital to buy tokens whereas, in an airdrop (or hard fork), tokens are allocated to existing holders of a particular chaintypically Bitcoin or Ethereum. Thats right, instead of buying tokens, theyre simply given away to the holders of another coin.

If the trend continues, Bitcoin and Ethereum are poised to spin-off dozens or hundreds of crypto-offspring. If so, this phenomenon could have significant implications for Bitcoin and Ether (the native asset of Ethereum) holdersand increase urgency for prospective holders. (Disclosure: My firm, Blockchain Capital, invests in blockchain startups and crypto assets including Bitcoin and Ether.)

Top 10 High Tech Stocks To Watch Right Now: Manitex International Inc.(MNTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrial shares fell by 0.08 percent. Meanwhile, top losers in the sector included Accenture Plc (NYSE: ACN), down 4 percent, and Manitex International Inc (NASDAQ: MNTX), down 4 percent.

Top 10 High Tech Stocks To Watch Right Now: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Top 10 High Tech Stocks To Watch Right Now: Liberty Global plc(LBTYA)

Advisors’ Opinion:

  • [By Alex Webb]

    Kabel Deutschland is a key part of Vodafones expansion strategy as the carrier looks for ways to boost revenue and lock in customers with Internet and television offers in addition to wireless service. Kabel Deutschland is the biggest cable company in Germany, Vodafones largest market, and had drawn a rival bid from John Malones Liberty Global Plc. (LBTYA)

  • [By Stephan Byrd]

    Liberty Global (NASDAQ: LBTYA) is one of 32 public companies in the “Cable & other pay television services” industry, but how does it contrast to its competitors? We will compare Liberty Global to related companies based on the strength of its institutional ownership, analyst recommendations, dividends, valuation, risk, profitability and earnings.

Top 10 High Tech Stocks To Watch Right Now: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:

  • [By Peter Graham]

    Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.

Top 10 High Tech Stocks To Watch Right Now: Brocade Communications Systems Inc.(BRCD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Broadcom Limited (NASDAQ: AVGO) and Brocade Communications Systems Inc. (NASDAQ: BRCD) disclosed a definitive deal through which the former would acquire the latter for $12.75 a share in cash. This would translate into a valuation of about $5.9 billion, including $0.4 billion of net debt.

Top 10 High Tech Stocks To Watch Right Now: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Keith Speights]

    Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

Top 10 High Tech Stocks To Watch Right Now: Wal-Mart Stores, Inc.(WMT)

Advisors’ Opinion:

  • [By Paul Ausick]

    The second-worst Dow Jones industrial average stock so far this year is Procter & Gamble Co. (NYSE: PG), which is down 14.6%. That is followed by Walmart Inc. (NYSE: WMT), down 12.2%, and DowDuPont Inc. (NYSE: DWDP) and Exxon Mobil Corp. (NYSE: XOM), both down 10.5%.

  • [By ]

    (1) Tesla (TSLA) will reportedly start producing its Model Y sport utility vehicle in November 2019. Can we just say what sane people (not the Tesla fanatics who continue to shred me on Twitter each day) are probably thinking: How in the world is Tesla going to successfully produce another vehicle, a more complex one at that, when it can’t even make money on what’s rolling off its fledgling production lines currently? And how is Tesla going to pull this new vehicle off without an injection of capital? The questions around Tesla’s survival are unending and rightfully so. (2) Who cares if Netflix (NFLX) has decided to pull out of the Cannes Film Festival – you see this company’s stock lately? Netflix has become far and away the best-performing member of the FAANG (Facebook (FB) , Apple (AAPL) , Amazon (AMZN) , Netflix, Alphabet (GOOGL) ) stock club this year. Here are five reasons why. (3) Oil prices are on fire, hovering around three-year highs on heightened geopolitical tensions. That’s bad news for consumer companies such as Walmart (WMT) given the associated rise in gas prices. Prices at the pump are up about 11% from this point last year, and some surveys see prices up at least 14% this summer.   

  • [By Paul Ausick]

    Wal-Mart Stores Inc. (NYSE: WMT) traded down 0.92% at $75.54. The stock’s 52-week range is $65.28 to $80.47. Volume was about 20% below the daily average of around 8.7 million. The company had no specific news.

  • [By Joe Tenebruso]

    Even discount chains such asTarget (NYSE:TGT) and the mighty Wal-Mart (NYSE:WMT) have seen their sales and margins dented by intensifying competition. For decades, these discount chains were the disruptors; with their wide selection of goods and low prices, they steadily claimed market share from their higher-priced and often smaller rivals.

Top 10 High Tech Stocks To Watch Right Now: Colony NorthStar, Inc. (CLNS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) slipped about 3.1% to post a new 52-week low of $11.02 Wednesday after closing at $11.37 on Tuesday. Volume of about 3.8 million was about 45% above the daily average of around 2.7 million. The REIT completed its sale of an investment management firm to Aon plc on Tuesday for net proceeds of around $379 million.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) dropped about 6.3% Tuesday to post a new 52-week low of $8.50 after closing at $9.07 on Monday. The stock’s 52-week high is $14.74. Volume was around 17.5 million, more than four times the daily average of around 3.9 million. The company had no specific news. Shares traded up about 1% late Tuesday afternoon at around $9.15.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) matched a 52-week low of $11.97 set last Friday. The 52-week high is $16.08. Volume was about 2.5 million, nearly equal to the daily average of around 2.6 million shares. The company had no specific news. Shares are on track to close with a gain of nearly 1%.

Top 10 High Tech Stocks To Watch Right Now: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By Jim Cramer]

    Despite the weak revenue results, PCAR has outperformed against the industry average of 21.6%. Since the same quarter one year prior, revenues slightly dropped by 1.6%. The declining revenue has not hurt the company’s bottom line, with increasing earnings per share.

     

  • [By Jim Cramer]

    PACCAR INC has improved earnings per share by 16.3% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, PACCAR INC increased its bottom line by earning $3.82 versus $3.30 in the prior year. This year, the market expects an improvement in earnings ($4.58 versus $3.82).

     

  • [By JPMorgan]

    We are Neutral on PCAR as the company faces the risk of both lower volume and margin pressure from declining demand in its core NA HD truck business in 2016. However, we believe PCAR should command a premium valuation due to its track record of solid execution. In addition, PCAR pays out a normal and a special dividend which, in total, should equal ~50% of net income and currently offers a yield of 4.1% (JPMe total payout of ~$2.12/share) making it potentially attractive to income-oriented investors. 

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Laurie Kulikowski]

    We rate PACCAR INC as a Buy with a ratings score of B-. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. 

  • [By Vikram Nagarkar]

    NVIDIA has also recently announced several partnerships lately, like the one with Microsoft,dubbed Olympus, aimed at maximizing GPU performance for data centers. Then there are also other partnerships in the self-driving cars space, like the one with Bosch, and another one with PACCAR (NASDAQ:PCAR), to develop autonomous trucks. Of course, most of these partnerships will most likely take a while before they can translate to any monetary benefits for NVIDIA. What these deals do, though, is reinforce NVIDIA’s grip over this market, which even pushed Intel (NASDAQ:INTC)to acquire Mobileye (NYSE:MBLY), to build a presence in this space. Mobileye is the company that lost business from Tesla Inc (NASDAQ:TSLA)to NVIDIA last year. Putting that aside, more importantly, the price that Intel is paying to acquire Mobileye has indirectly pointed to the fact that NVIDIA may be significantly undervalued.

Top 10 High Tech Stocks To Watch Right Now: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Lisa Levin]

    Rent-A-Center Inc (NASDAQ: RCII) was down, falling around 26 percent to $9.88. Rent-A-Center reported upbeat quarterly earnings, but the company’s sales missed analysts’ estimates.

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Q1 2018 EPS Estimates for Rent-A-Center Increased by KeyCorp (RCII)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3350595/q1-2018-eps-estimates-for-rent-a-center-increased-by-keycorp-rcii.html.